Biocon Ltd (BION.NS) Quote| Reuters.com
Edition:
United States

Biocon Ltd (BION.NS)

BION.NS on National Stock Exchange of India

741.20INR
30 Jun 2016
Change (% chg)

-- (--)
Prev Close
Rs741.20
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
842,478
52-wk High
Rs765.00
52-wk Low
Rs395.30

BION.NS

Chart for BION.NS

About

Biocon Limited is an India-based company that manufactures pharmaceuticals, medicinal chemical and botanical products. The Company is engaged in developing biologics and biosimilars for addressing chronic diseases, such as cancer, diabetes and autoimmune conditions for patients across the world. Its products include Insugen,... (more)

Overall

Beta: 0.42
Market Cap(Mil.): Rs148,040.00
Shares Outstanding(Mil.): 200.00
Dividend: 5.00
Yield (%): 1.35

Financials

  BION.NS Industry Sector
P/E (TTM): 16.52 41.10 35.71
EPS (TTM): 44.81 -- --
ROI: 17.34 -6.56 14.23
ROE: 24.46 -5.98 15.43

BRIEF-Mylan and Biocon to present phase 3 trastuzumab biosimilar data at ASCO annual meeting

* Mylan and Biocon to present phase 3 trastuzumab biosimilar data at the American Society Of Clinical Oncology (ASCO) annual meeting

Jun 03 2016

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Thomson Reuters Stock Report
$25.00
Provider : Reuters Investment Profile
$20.00
Provider : Wright Reports
$75.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.